A5065814388- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Chemotherapy-related skin toxicity
- Cancer-related cognitive impairment studies
- Breast Cancer Treatment Studies
- Management of metastatic bone disease
- HER2/EGFR in Cancer Research
- BRCA gene mutations in cancer
- Monoclonal and Polyclonal Antibodies Research
- Silymarin and Mushroom Poisoning
Innsbruck Medical University
2022-2025
Universität Innsbruck
2022-2025
Background: In early-stage breast cancer with initially positive axillary lymph nodes, reliable assessment of the involvement axilla is important because prognostic importance lymph-node metastases. After neoadjuvant chemotherapy (NACT) targeted dissection (TAD) including sentinel biopsy and primarily involved currently regarded as standard care. The target node must be marked using a clip/marker later localized guidance technique to identify avoid indication dissection. Methods: present...
This study aimed to demonstrate the superiority of cryocompression over cryotherapy alone in prevention chemotherapy-induced peripheral neuropathy (CIPN) grade 2 or above.
Endocrine treatment (ET) is a highly effective breast cancer but can distinctly impair patients' quality of life (QOL). In patient-reported outcome (PROs) study conducted by the authors in 2011, patients reported higher ET-induced symptom levels than known from registration trials, and was underestimated. Based on these results, we investigated long-term sequelae ET survivors (BCS) follow-up 5-10 years after an earlier assessment.BCS who had participated (n = 436) were approached for...
1079 Background: As constant advancements in cancer therapy were able to improve overall survival for gynecological cancers drastically, impact on patients’ quality of life (QoL) and longtime effects gain importance treatment planning. Chemotherapy-induced peripheral neuropathy (CIPN) is one the most detrimental side taxane-based chemotherapy (CT). According recent literature up 87% patients receiving CT suffer from CIPN grade two or above. Symptoms include sensory motor deficits, which...
Abstract Background: Endocrine treatment (ET) is a highly effective breast cancer but can distinctly impair patients’ quality of life (QOL). In patient-reported outcome (PROs) study conducted by the authors in 2011, patients reported higher ET-induced symptom levels than known from registration trials, and was underestimated. Based on these results, we investigated long-term sequelae ET survivors (BCS) follow-up 5-10 years after an earlier assessment. Methods : BCS who had participated...